Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose)

Uwe Koedel1, Frank Winkler, Barbara Angele

  • 1Department of Neurology, Klinikum Grosshadern, Munich, Germany.

Insights

Poly(adenosine diphosphate-ribose) polymerase (PARP) activation contributes to brain injury in experimental pneumococcal meningitis. Inhibiting PARP protects against central nervous system complications and reduces inflammation, suggesting PARP inhibitors as potential therapies.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Pneumococcal meningitis can cause severe central nervous system (CNS) complications.
  • The role of poly(adenosine diphosphate-ribose) polymerase (PARP) activation in meningitis pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate the role of PARP activation in experimental pneumococcal meningitis.
  • To evaluate the therapeutic potential of PARP inhibition.

Main Methods:

  • Utilized PARP 1 gene-deficient mice and wild-type mice infected with Streptococcus pneumoniae.
  • Administered the PARP inhibitor 3-aminobenzamide.
  • Assessed CNS complications, including blood-brain barrier integrity and intracranial pressure.
  • Measured inflammatory markers (cytokines, leukocytes) in cerebrospinal fluid and brain tissue.
  • Examined PARP activation and nicotinamide adenine dinucleotide levels in endothelial cells exposed to pneumococci.

Main Results:

  • PARP 1 deficiency protected mice from meningitis-associated CNS complications and inflammation.
  • PARP inhibition with 3-aminobenzamide conferred similar protection, reducing inflammation and improving clinical outcomes.
  • Pneumococcal challenge induced PARP activation and endothelial cell death, which was attenuated by 3-aminobenzamide.
  • PARP activation correlated with reduced cellular nicotinamide adenine dinucleotide levels and increased cytotoxicity.

Conclusions:

  • PARP activation plays a critical role in the pathogenesis of pneumococcal meningitis and associated CNS injury.
  • PARP inhibition demonstrates therapeutic potential for treating bacterial meningitis.
  • Targeting PARP activation may mitigate pneumococci-induced endothelial damage.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...